PCSK9 and neoplasm: Furthermore, flow cytometry detection demonstrated that PCSK9 inhibition increased the infiltration ratio of CD8+ T cells (P = 0.0015) and DCs (P = 0.0024) and promoted the expression of MHC-II (P = 0.0097) on the surface of tumor cells (Figure S7).